Investment Summary |
|
|---|---|
| Date | 2004-03-01 |
| Target | Tag |
| Sector | Marketing |
| Investor(s) | 3i Private Equity |
| Deal Type | Growth Capital |
| Deal Value | 20M GBP |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1945 |
| PE ASSETS | 21.0B GBP |
| Size | Mega |
| Type | Sector Agnostic |
3i Private Equity is the private equity arm of 3i Group, a publicly held, global investment firm focused on private equity and infrastructure investing. 3i Private Equity generally targets buyout and growth capital financings and looks for opportunities across Europe, North America, and Asia. The Firm's targeted transaction range is €100 to €500 million. Industries of interest include business services, healthcare, consumer, media, oil/gas & power, technology, and financial services. 3i Group was originally formed in 1945 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 64 of 251 |
| Sector: Marketing M&A | 1 of 4 |
| Type: Growth Capital M&A Deals | 8 of 52 |
| Country: United Kingdom M&A | 33 of 70 |
| Year: 2004 M&A | 10 of 33 |
| Size (of disclosed) | 51 of 64 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-03-01 |
Smart & Cook Group
Harrogate, United Kingdom Smart & Cook Group Ltd. is an insurance, risk management and financial services groups. It offers insurance broking and consultancy services for corporate clients including insurance due diligence services. It has three revenue streams: commercial insurance, consultancy and financial services. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-03-08 |
betapharm Arzneimittel
Augsburg, Germany Betapharm markets high quality generic drugs focusing on long-term therapy products with high prescription rates. |
Buy | €300M |